Literature DB >> 18333224

MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.

Khaled M Elsayes1, John R Leyendecker, Christine O Menias, Erica P Oliveira, Vamsidhar R Narra, William C Chapman, Moataz H Hassanien, Mohamed S Elsharkawy, Jeffrey J Brown.   

Abstract

OBJECTIVE: To evaluate the diagnostic yield of MRI performed for characterization of focal hepatic lesions that are interpreted as indeterminate on CT. PATIENTS AND METHODS: In a retrospective investigation, 124 indeterminate focal hepatic lesions in 96 patients were identified on CT examinations over 5 years from 1997 to 2001. All patients had MRI performed for the liver within 6 weeks of their CT examination. CT and MR images were reviewed independently by two separate groups of two radiologists. The value of MRI in characterizing these lesions was assessed. Diagnoses were confirmed based on histology, characteristic imaging features, and clinical follow-up.
RESULTS: MRI definitely characterized 73 lesions (58%) that were indeterminate on CT. MRI was accurate in 72/73 of these lesions. MRI could not definitely characterize 51 lesions (42%). Ten lesions were not visualized on MRI, and follow-up imaging confirmed that no lesion was present in eight of these cases (pseudolesions).
CONCLUSION: MRI is valuable for the characterization of indeterminate focal hepatic lesions detected on CT.

Entities:  

Year:  2007        PMID: 18333224      PMCID: PMC2063603          DOI: 10.1080/13651820701216950

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  39 in total

1.  Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?

Authors:  Curtis H Coulam; Frandics P Chan; King C P Li
Journal:  AJR Am J Roentgenol       Date:  2002-02       Impact factor: 3.959

2.  T2-weighted MR imaging in the assessment of cirrhotic liver.

Authors:  Hero K Hussain; Ibrahim Syed; Hanh V Nghiem; Timothy D Johnson; Ruth C Carlos; William J Weadock; Isaac R Francis
Journal:  Radiology       Date:  2004-01-22       Impact factor: 11.105

3.  Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.

Authors:  S P Quillin; S Atilla; J J Brown; J A Borrello; C Y Yu; T K Pilgram
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

4.  Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.

Authors:  B Hamm; E Fischer; M Taupitz
Journal:  J Comput Assist Tomogr       Date:  1990 Mar-Apr       Impact factor: 1.826

5.  Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.

Authors:  H Yoshida; Y Itai; K Ohtomo; T Kokubo; M Minami; N Yashiro
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

6.  Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.

Authors:  W S Whitney; R J Herfkens; R B Jeffrey; C H McDonnell; K C Li; W J Van Dalsem; R N Low; I R Francis; J F Dabatin; G M Glazer
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

7.  Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.

Authors:  A E Mahfouz; B Hamm; K J Wolf
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

8.  Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT.

Authors:  R E Larson; R C Semelka; A S Bagley; P L Molina; E D Brown; J K Lee
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

9.  The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.

Authors:  E C Jones; J L Chezmar; R C Nelson; M E Bernardino
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

Review 10.  Hemangioma from head to toe: MR imaging with pathologic correlation.

Authors:  Joan C Vilanova; Joaquim Barceló; James G Smirniotopoulos; Ricard Pérez-Andrés; Miguel Villalón; Josefina Miró; Ferran Martin; Jaume Capellades; Pablo R Ros
Journal:  Radiographics       Date:  2004 Mar-Apr       Impact factor: 5.333

View more
  8 in total

1.  Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging.

Authors:  Michael Soussan; Christophe Aubé; Stéphane Bahrami; Jérôme Boursier; Dominique Charles Valla; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2010-01-13       Impact factor: 5.315

Review 2.  Hepatocellular carcinoma: a review of the surgical approaches to management.

Authors:  Bernard J DuBray; William C Chapman; Christopher D Anderson
Journal:  Mo Med       Date:  2011 May-Jun

3.  Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim; Jisun Lee; Kyoung Doo Song; Min Woo Lee; Young-Sun Kim; Hyo Keun Lim; Kyung Mi Jang; Seong Hyun Kim; Geum-Youn Gwak; Sin-Ho Jung
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

4.  Outcome of indeterminate liver lesions on computed tomography in patients with colorectal cancer.

Authors:  E Mohamed; A Adiamah; W K Dunn; Y Higashi; I C Cameron; D Gomez
Journal:  Ann R Coll Surg Engl       Date:  2018-04-25       Impact factor: 1.891

5.  Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients.

Authors:  John N Morelli; Henrik J Michaely; Mathias M Meyer; Thassilo Rustemeyer; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  HYPERVASCULAR LIVER LESIONS IN RADIOLOGICALLY NORMAL LIVER.

Authors:  Enio Campos Amico; José Roberto Alves; Dyego Leandro Bezerra de Souza; Fellipe Alexandre Macena Salviano; Samir Assi João; Adriano de Araújo Lima Liguori
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

Review 7.  Use of contrast agents in oncological imaging: magnetic resonance imaging.

Authors:  Giovanni Morana; Christian Cugini; Giuliano Scatto; Riccardo Zanato; Michele Fusaro; Alberto Dorigo
Journal:  Cancer Imaging       Date:  2013-09-23       Impact factor: 3.909

Review 8.  Advances in liver US, CT, and MRI: moving toward the future.

Authors:  Federica Vernuccio; Roberto Cannella; Tommaso Vincenzo Bartolotta; Massimo Galia; An Tang; Giuseppe Brancatelli
Journal:  Eur Radiol Exp       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.